Response to ZDV/ddI Containing Combination Antiretroviral Therapy Among HIV-1 Subtype C Infected Adults in Botswana: Two-Year Outcomes from a Randomized Clinical Trial

BACKGROUND: Numerous national antiretroviral (ARV) treatment initiatives offering protease-inhibitor (PI)-sparing combination antiretroviral therapy (cART) have recently commenced in southern Africa, the first of which began in Botswana in January 2002. Evaluation of the efficacy and tolerability of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Bussmann, Hermann, Wester, C. William, Thomas, Ann, Novitsky, Vladimir, Okezie, Reginald, Muzenda, Tanaka, Gaolathe, Tendani, Ndwapi, Ndwapi, Mawoko, Norah, Widenfelt, Erik, Moyo, Sikhulile, Musonda, Rosemary, Mine, Madisa, Makhema, Joseph, Moffat, Howard, Essex, Max, DeGruttola, Victor, Marlink, Richard
Formato: Artigo
Lenguaje:Inglês
Publicado: 2009
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3066172/
https://ncbi.nlm.nih.gov/pubmed/19282782
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0b013e31819ff102
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares